• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

7wireVentures Launches $217M Growth & Opportunity Fund to Support Later-Stage Digital Health Investments

Share:

October 10, 2023

7wireVentures, a digital health venture capital firm, has successfully closed a $217 million Growth & Opportunity “GO” Fund, its largest to date. The fund will support later-stage digital health investments in existing portfolio companies and new opportunities. Three investments have already been made from the fund, including NOCD, FOLX Health, and Parsley Health. 7wireVentures focuses on consumer-first, technology-enabled healthcare solutions, empowering informed connected healthcare consumers. The firm’s assets under management now exceed $500 million.

What You Should Know:

– 7wireVentures, one of the country’s leading digital health venture capital firms, today announced the successful completion of a $217 million Growth & Opportunity “GO” Fund, its largest to date.

– The new venture fund will support later-stage digital health investments in high-potential companies from existing portfolios as well as new opportunities. The closing of the $217M GO Fund brings the Firm’s assets under management (AUM) to over $500M.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

GO Fund Investments to Date

The new capital supports the Firm’s existing mandate to invest in consumer-first, technology-enabled solutions that empower Informed Connected Healthcare Consumers. 7wireVentures has already completed three investments out of the GO Fund, including current portfolio company, NOCD, a specialty mental illness company focused on obsessive compulsive disorder, FOLX Health, the market’s first virtual healthcare platform which addresses the needs of the LGBTQIA+ community, and Parsley Health, a specialized virtual clinic designed to help complex chronic patients get better and feel better while reducing total cost of care.

“We are excited to announce the successful closing of our new Growth & Opportunity Fund – affirming investors’ continuing belief in our consumer-driven digital health approach,” said Managing Partner, Glen Tullman. “After nearly a decade of success, we are now prepared to double down on some of our fastest growing and most impactful companies while we continue to widen our aperture to exceptional later growth-stage opportunities across the industry.”

7wireVentures Background
Founded over a decade ago by serial entrepreneurs Glen Tullman and Lee Shapiro, 7wireVentures has built a portfolio of 23 companies and a strategic coalition of more than a dozen leading healthcare organizations, together impacting the health and care of millions of Americans. Joined by Partners Robert Garber and Alyssa Jaffee, 7wireVentures provides a unique array of sector and operational experience, and deep industry relationships driving enhanced growth across the Firm’s portfolio. Fund successes, such as Livongo, are due in large part because the team includes both seasoned operators and investors with extensive industry experience. Being highly selective with investments, the Fund works side-by-side with founders to build companies that change the status quo and empower consumers to be better stewards of their health.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Teladoc Health Pursuing Growth Through Tech InvestmentsTeladoc Health Pursuing Growth Through Tech Investments
  • GSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security MarketGSAC Engineering Acquires Key Intellectual Property and Assets from Duos Technologies GroupGelStat’s Subsidiary, GSAC Engineering, Launches Intelligent Correctional Facilities Automation Systems (iCAS) in the Industrial Security Market
  • Marathon Asset Management Announces Acquisition of KaléoMarathon Asset Management Announces Acquisition of Kaléo
  • Quest Diagnostics Acquires PhenoPath, Broadening Access to Advanced DiagnosticsQuest Diagnostics Acquires PhenoPath, Broadening Access to Advanced Diagnostics
  • Pleno Secures $40M to Disrupt Sequencing Market, Scale Multi-OmicsPleno Secures $40M to Disrupt Sequencing Market, Scale Multi-Omics
  • LipoCoat Snaps up €1.5 Million to Market Its Infection Control TechLipoCoat Snaps up €1.5 Million to Market Its Infection Control Tech
  • Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes to Expand Manufacturing CapabilitiesVector Laboratories Acquires Click Chemistry Tools and Fluoroprobes to Expand Manufacturing Capabilities
  • Phoenix Rehabilitation & Health Services, Inc. Acquires CACC Physical TherapyPhoenix Rehabilitation & Health Services, Inc. Acquires CACC Physical Therapy

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications